26 September 2012
Effective optimization of living donor kidney transplantation activity ensuring adequate donor safety
Michał Ciszek, Leszek Pączek, Paweł Łuków, Wojciech RowińskiDOI: 10.12659/AOT.883464
Ann Transplant 2012; 17(3): 103-110
Abstract
Results of kidney transplantation are excellent, but the number of patients on the waiting lists far exceeds the number of available organs. Living kidney donation must be considered as an important part of organ transplantation programmes. In the European Union countries, nearly 20% of all kidney transplants in 2010 were done with organs from living donors. However, the proportion of live donor kidney transplantation between EU countries varies greatly: from 3% to 54% of all kidney transplantations. Multiple initiatives have been undertaken in most of the European countries to increase the number of living donor kidney transplantations. In some countries widening of the donor pool has nearly reached the limits by accepting altruistic donors, paired and group exchanges, and even by performing live donor kidney transplantation in highly immunized recipients. There is a great need to optimize living donor kidney transplantation programmes by using a new strategy of: a. Detailed and adequate medical and psychosocial evaluation, ensuring that the need to increase programme activity will not overshadow the most important principle – donor safety. b. Total removal of all disincentives and financial obstacles that discourage potential donors, and provision of financial coverage for the follow-up. c. Sufficient detailed information about the option of living donor kidney transplantation, its results, and donor safety, delivered to relatives of patients with end-stage renal disease and to the patients themselves.
Keywords: Living Donor, Kidney Transplantation, strategy
In Press
Clinical Research
Prognostic Prediction in Living Donor Liver Transplantation Recipients With Complete Pathological Response ...Ann Transplant In Press; DOI: 10.12659/AOT.954574
Most Viewed Current Articles
24 Aug 2021 : Review article 22,345
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Dec 2021 : Original article 18,520
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
29 Sep 2015 : Review article 17,710
Risk Factors for Chronic Renal Insufficiency Following Cardiac TransplantationDOI :10.12659/AOT.893788
Ann Transplant 2015; 20:576-587
22 Nov 2022 : Original article 17,096
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






